Figure 2.
RFS following HCT in patients with MDS or AML randomized to receive maintenance azacitidine vs supportive care.

RFS following HCT in patients with MDS or AML randomized to receive maintenance azacitidine vs supportive care.

Close Modal

or Create an Account

Close Modal
Close Modal